The Covid-19 pandemic has posed existential questions regarding clinical trials: namely, how they should be conducted under conditions of lockdown and social distancing. Yourway has led the industry in advocating and implementing direct-to-patient drug delivery as a method of safely and efficiently ensuring continued drug development.